A missing piece of the jigsaw in a rare life-threatening condition linked to vaccines

A missing piece of the jigsaw in a rare life-threatening condition linked to vaccines

A team of scientists led by the University of Aberdeen has taken an important step forward in understanding the mechanisms by which adenovirus-based vaccines, including some of those used in the Covid pandemic, can cause serious adverse reactions.

Working in collaboration with NHS Grampian, NHS Greater Glasgow & Clyde and NHS Lothian, they have identified a new key feature of the ultra-rare condition termed Vaccine Induced Immune Thrombocytopenia and Thrombosis (VITT). This life-threatening condition is associated with the adenovirus-based vaccines to Covid-19, including Oxford-Astra Zeneca and Johnson-Johnson.

During the vaccine rollout, a small number of previously healthy people became rapidly unwell after vaccination and developed sometimes fatal blood clots or bleeding abnormalities. Patients with VITT have unique antibodies to a protein called platelet factor 4 (PF4). The antibodies cause activation of small cell fragments in the blood called, platelets, and trigger blood clotting. In the case of VITT blood clots were often present in unusual sites such as the brain, gut and liver.

The team led by Professor Nicola Mutch analysed samples from all suspected cases of VITT from across Scotland. Some of these patients were confirmed to have this rare condition based on the presence of antibodies to PF4 and other clinical features, including the presence of blood clots. Analysis of the samples from these patients found that there was overactivation of the body’s natural ‘blood clot busting system’, termed fibrinolysis. Uncontrolled fibrinolysis results in breakdown of the main building block of a blood clot, called fibrinogen.

Published in the Journal of Thrombosis & Haemostasis, these important observations help explain both the clot formation and the bleeding complications, commonly intracranial haemorrhage, seen in VITT patients.

This missing piece of the jigsaw is vital, as adenoviruses are used in other aspects of medicine, including as vectors in gene therapy for cancers and haemophilia. Understanding the mechanisms by which adenovirus-based products can cause adverse reactions, like VITT, is crucial in considering future use in other medicinal products. It may also guide therapeutic strategies to treat similar conditions to VITT in the future.

In this study, all samples from suspected cases of VITT seen in Scottish hospitals were included in the analysis. This allowed the team to make comparisons between patients with a VITT diagnosis and those initially suspected but who were ultimately found to be negative for the condition.  Patients with VITT showed a very high incidence of a complication called disseminated intravascular coagulation (DIC), a severe abnormality in the blood clotting cascade which can cause organ damage and uncontrollable bleeding. In patients with VITT there was also evidence of excessive breakdown of these blood clots and their precursor, fibrinogen, suggesting overactivation of fibrinolysis.

Emeritus Professor, Henry Watson explains: “This research was triggered by the recognition of the catastrophic outcomes of VITT, in which previously healthy, frequently young individuals were becoming rapidly unwell. This extremely rare but often fatal reaction to the adenovirus-based Covid-19 vaccine usually occurred around 7 to 30 days after vaccination.

“Given that Aberdeen held all of the Scottish samples of suspected VITT, we quickly realised this was a unique opportunity to help define the features of this complex syndrome and how it differs from other thrombotic conditions.” 

Professor Nicola Mutch adds: “Our work identifies a novel aspect of VITT which was previously unrecognised. It helps us to understand the mechanisms underlying the clinical observations, whereby the patients suffer from complications due to both blood clots and bleeding at the same time.

“The demonstration of overt disseminated intravascular coagulation and the breakdown of the clotting protein fibrinogen in VITT had not previously been recognised but this helps explain the acute symptoms and rapid course of this extremely rare complication of vaccination with adenovirus-based vaccines. “

The work was funded by The University of Aberdeen Development Trust SCIO.

University of Aberdeen Director of Advancement, Liza Boffen-Yordanov said: “We are grateful to the donors whose generous gifts enabled this critical research to be undertaken. Their philanthropic support meant our researchers were able to respond quickly to the emergence of this rare condition in response to certain vaccines.”

Search News

Browse by Month

2024

  1. Jan
  2. Feb There are no items to show for February 2024
  3. Mar
  4. Apr
  5. May There are no items to show for May 2024
  6. Jun There are no items to show for June 2024
  7. Jul There are no items to show for July 2024
  8. Aug There are no items to show for August 2024
  9. Sep There are no items to show for September 2024
  10. Oct There are no items to show for October 2024
  11. Nov There are no items to show for November 2024
  12. Dec There are no items to show for December 2024

2023

  1. Jan There are no items to show for January 2023
  2. Feb There are no items to show for February 2023
  3. Mar There are no items to show for March 2023
  4. Apr There are no items to show for April 2023
  5. May There are no items to show for May 2023
  6. Jun There are no items to show for June 2023
  7. Jul There are no items to show for July 2023
  8. Aug There are no items to show for August 2023
  9. Sep There are no items to show for September 2023
  10. Oct
  11. Nov There are no items to show for November 2023
  12. Dec

2022

  1. Jan
  2. Feb There are no items to show for February 2022
  3. Mar
  4. Apr There are no items to show for April 2022
  5. May
  6. Jun There are no items to show for June 2022
  7. Jul
  8. Aug
  9. Sep There are no items to show for September 2022
  10. Oct
  11. Nov There are no items to show for November 2022
  12. Dec There are no items to show for December 2022

2021

  1. Jan There are no items to show for January 2021
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2020

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2020
  9. Sep There are no items to show for September 2020
  10. Oct There are no items to show for October 2020
  11. Nov
  12. Dec

2019

  1. Jan
  2. Feb
  3. Mar There are no items to show for March 2019
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2018

  1. Jan There are no items to show for January 2018
  2. Feb There are no items to show for February 2018
  3. Mar There are no items to show for March 2018
  4. Apr There are no items to show for April 2018
  5. May There are no items to show for May 2018
  6. Jun There are no items to show for June 2018
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2017

  1. Jan
  2. Feb There are no items to show for February 2017
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2017
  9. Sep
  10. Oct There are no items to show for October 2017
  11. Nov
  12. Dec There are no items to show for December 2017

2016

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2016
  9. Sep
  10. Oct
  11. Nov There are no items to show for November 2016
  12. Dec

2014

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep There are no items to show for September 2014
  10. Oct
  11. Nov
  12. Dec

2012

  1. Jan There are no items to show for January 2012
  2. Feb There are no items to show for February 2012
  3. Mar There are no items to show for March 2012
  4. Apr There are no items to show for April 2012
  5. May There are no items to show for May 2012
  6. Jun There are no items to show for June 2012
  7. Jul There are no items to show for July 2012
  8. Aug There are no items to show for August 2012
  9. Sep
  10. Oct
  11. Nov There are no items to show for November 2012
  12. Dec There are no items to show for December 2012